New treatment target for diabetic kidney disease
Friday, May 27, 2011 - 06:00
in Health & Medicine
(Medical Xpress) -- UC Davis investigators have shown that blocking a specific receptor pathway could slow or even prevent diabetic nephropathy an often fatal complication of diabetes for which there are few good treatment options. Published online today (May 26) in the journal Arteriosclerosis, Thrombosis and Vascular Biology, the study is the first to clarify the role of the receptor toll-like receptor 2, or TLR2 in diabetes-associated kidney disease.